244 related articles for article (PubMed ID: 33270989)
21. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
22. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer.
Okubo K; Arigami T; Matsushita D; Kijima T; Shimonosono M; Uenosono Y; Yanagita S; Kurahara H; Mori S; Ohtsuka T; Natsugoe S
BMC Cancer; 2021 Jan; 21(1):95. PubMed ID: 33485312
[TBL] [Abstract][Full Text] [Related]
25. Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
Okubo K; Arigami T; Matsushita D; Tanaka T; Tsuruda Y; Noda M; Sasaki K; Mori S; Kurahara H; Ohtsuka T
Oncology; 2021; 99(6):380-388. PubMed ID: 33677434
[TBL] [Abstract][Full Text] [Related]
26. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
27. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
28. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
[TBL] [Abstract][Full Text] [Related]
29. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
Tong Y; Zhao Y; Shan Z; Zhang J
BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
[TBL] [Abstract][Full Text] [Related]
30. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
33. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
[TBL] [Abstract][Full Text] [Related]
34. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
[TBL] [Abstract][Full Text] [Related]
35. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion.
Imai Y; Kurata Y; Ichinose M
BMC Gastroenterol; 2023 May; 23(1):189. PubMed ID: 37254045
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
Zheng HL; Wei LH; Xu BB; Zheng HH; Xue Z; Chen QY; Xie JW; Zheng CH; Huang CM; Lin JX; Li P
Eur J Surg Oncol; 2024 Mar; 50(3):108004. PubMed ID: 38330540
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery.
Warschkow R; Tarantino I; Ukegjini K; Beutner U; Müller SA; Schmied BM; Steffen T
Langenbecks Arch Surg; 2012 Jun; 397(5):727-36. PubMed ID: 22398436
[TBL] [Abstract][Full Text] [Related]
40. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
